Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Towards Elimination of Cervical Cancer – Human Papillomavirus (Hpv) Vaccination and Cervical Cancer Screening in Asian National Cancer Centers Alliance (Ancca) Member Countries Publisher



Ong SK1 ; Abe SK2 ; Thilagaratnam S3 ; Haruyama R4 ; Pathak R5 ; Jayasekara H6 ; Togawa K2 ; Bhandari AKC2 ; Shankar A7 ; Nessa A8 ; Jugder U9 ; Agustina J10 ; Biglari M11 ; Yusuf A12 Show All Authors
Authors
  1. Ong SK1
  2. Abe SK2
  3. Thilagaratnam S3
  4. Haruyama R4
  5. Pathak R5
  6. Jayasekara H6
  7. Togawa K2
  8. Bhandari AKC2
  9. Shankar A7
  10. Nessa A8
  11. Jugder U9
  12. Agustina J10
  13. Biglari M11
  14. Yusuf A12
  15. Tshomo U13
  16. Fernando E14
  17. Cairo C15
  18. Kaung KK16
  19. Rath B17
  20. Vongdala C18
  21. Pradhananga KK19
  22. Kim J20
  23. Chung YK20
  24. Thanh Huong TT21
  25. Sangrajran S22
  26. Zhang Y23
  27. Basu P24
  28. Woo YL25
  29. Sukumaran B26
  30. Hwang WYK27

Source: The Lancet Regional Health - Western Pacific Published:2023


Abstract

About 95% of cervical cancers worldwide are caused by human papillomavirus (HPV). Cervical cancer is preventable and curable if it is detected and treated early. We reviewed the latest national cervical cancer indicators, and barriers to HPV vaccination and cervical cancer screening in 21 Asian National Cancer Centers Alliance (ANCCA) member countries. Half (n = 11, 52%) of the countries have introduced HPV vaccination for girls as part of their national vaccination programme, three countries reported coverage of over 90%. Most ANCCA member countries have cervical cancer screening programmes, only five countries reported screening uptake of over 50%. The barriers to HPV vaccination coverage and cervical cancer screening participation have been identified. Ensuring health service accessibility and affordability for women, addressing sociocultural barriers, and strengthening the healthcare system and continuum of care are essential to increase HPV vaccination and cervical cancer screening coverage. © 2023
1. Lifetime Prevalence of Cervical Cancer Screening in 55 Low-And Middle-Income Countries, JAMA - Journal of the American Medical Association (2020)
3. Delayed Cervical Cancer Diagnosis: A Systematic Review, European Review for Medical and Pharmacological Sciences (2022)
Experts (# of related papers)
Other Related Docs
16. Regular Cervical Cancer Screening for Iranian Women: Facilitators and Barriers, Journal of Qualitative Research in Health Science (2020)